Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Real Time & Level II Data
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Telo Genomics Corp
V.TELO
Alternate Symbol(s):
TDSGF
Healthcare
Industrials
Biotechnology
Conglomerates
Telo Genomics Corp. is a Canada-based biotech company. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. The Company offers telomere platform which consists of applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and...
neurological diseases. Its lead application, TELO-MM is being developed to provide important, actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. The Company’s product, TeloView is a technology which consists of two parts, analytical software and a corresponding report designed for clinical decision making. Its TeloView software generates a report for the clinician that contains information, including the stage of a given disease, its rate of progression and how it responds to therapy.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:TELO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(0)
•••
lance1997
X
Post by
lance1997
on Aug 06, 2023 7:03am
August
Phase 1 should be ongoing now.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on May 17, 2023 10:46am
82% Accurate Blood Test
$TDSGF $TELO.V 82% Accurate Blood Test SEE: European Hematology Association Abstract P975 https://library.ehaweb.org/eha/2023/eha2023-congress/386804/shaji.kumar
...more
Argentina Lithium Announces US$90 Million Investment by Stellantis
posted Sep 29, 2023 9:00am by
Argentina Lithium & Energy Corp.
-
|
Stellantis, one of the world's leading automakers has agreed to invest US$90 million in Argentina to acquire shares of ALE. The proceeds of the Transaction will be used to advance development of the Company's lithium projects held through its wholly owned subsidiary in Argentina. ...read more
(0)
•••
westdakotadave
X
Post by
westdakotadave
on May 17, 2023 10:44am
TeloGenomics Mayo Abstract
$TDSGF $TELO.V TeloGenomics Mayo Clinic results presented at ASCO. https://meetings.asco.org/abstracts-presentations/226578
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 18, 2023 12:13pm
$TDSGF Mayo Clinic Results
$TELO.V $TDSGF The Mayo Clinic study "has exceeded its targeted endpoints". See 9/14/2022 Press Release.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 15, 2023 3:23pm
TeloGenomics @ ASCO with approved Abstract
It is at ASCO at Booth IH18 from June 2-6, 2023 not at ASH as posted befoere this.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Apr 15, 2023 3:21pm
TeloGenomics @ASCO
ASCO Abstract approved for release and publication. See Telo Genomics at Booth 3243 at ASH 2022 Conference.
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Mar 21, 2023 11:10am
$TDSGF
$TDSGF Telo Genomics at Booth IH18 from June 2-6, 2023 at American Society of Clinical Oncology (ASCO).
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Mar 17, 2023 2:12pm
$TDSGF GAMEPLAN
$TDSGF GAMEPLAN per Feb 28, 2023 Filing (SEDAR MD&A) March 2023 = Mayo SMM results have been submitted to the American Society of Clinical Oncology (ASCO) for presentation. June 2023
...more
(0)
•••
westdakotadave
X
Post by
westdakotadave
on Nov 01, 2022 1:02pm
TELO Abstract
American Society of Hematology (ASH) Abstract Schedule Abstracts available online November 3, 2022, 9:00 a.m. Eastern time Late-breaking abstracts available online November 22, 2022. ASH ANNUAL
...more
(6)
•••
toasted101
X
Post by
toasted101
on Jul 13, 2022 6:26pm
Telo Clinical Study of Drug Resistance for Multiple Myeloma
Telo Genomics Launches Clinical Study of Drug Resistance Test for Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - July 13, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the
...more
(21)
•••
bandi10
X
Post by
bandi10
on Jul 07, 2022 12:18pm
news
Telo Genomics Completes Processing and Analysis of Smoldering Multiple Myeloma Patient Samples Toronto, Ontario--(Newsfile Corp. - July 6, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF
...more
(6)
•••
toasted101
X
Post by
toasted101
on May 31, 2022 10:04am
Telo Announces Validation of Its Proprietary Tools for SMM
Telo Genomics Announces Successful Validation of Its Proprietary Automation Tools for Smoldering Multiple Myeloma Toronto, Ontario--(Newsfile Corp. - May 31, 2022) - Telo Genomics Corp. (TSXV
...more
(21)
•••
bandi10
X
Post by
bandi10
on Apr 11, 2022 7:25pm
huge volume
Something good must be up for this volume of today.
(6)
•••
toasted101
X
Post by
toasted101
on Mar 07, 2022 9:59am
Telo Clinical Validation of its Smoldering Myeloma Test
Telo Genomics Launches Clinical Validation of its Smoldering Multiple Myeloma Diagnostic Test Toronto, Ontario--(Newsfile Corp. - March 7, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF
...more
(6)
•••
toasted101
X
Comment by
toasted101
on Feb 03, 2022 6:23pm
RE:news
Dr. McGlennen is a strong addition to the Telo team that should prove beneficial in taking Telo to commercialization. https://www.telodx.com
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Metallurgical Test Program at Los Cuyes Yielded Excellent Gold Recoveries
Eminent Gold has signed a purchase & sale agreement with Orogen Royalties for property in Nevada
Copper Exploration Company is on the Edge of a Big Discovery
Harness the Power: Elevate Your Understanding of Battery Metals & EVs - Free Insights Report Av alible
Energy Co. Announces Low Dilutive Development Capital Raise